Table 1.
Groups | Typical metabolites | Typical targets | Specific functions | Typical diseases associated | Ref. |
---|---|---|---|---|---|
Short-chain fatty acids | Acetate, propionate, butyrate, hexanoate, isovalerate, isobutyrate, 2-methylpropionate, valerate |
Directly act on GPR41, GPR43, GPR109A, GPR81, GPR91, HDAC1 and HDAC3 | Regulation of gut microbiota composition, gut barrier integrity, appetite, energy homeostasis, gut hormone production, circadian clocks; inhibit proinflammatory cytokines; stimulate water and sodium absorption; modulate systemic immune response | Diabetes, obesity, pancreatitis, nonalcoholic fatty liver disease, hypertension, atherosclerosis, chronic kidney disease, ulcerative colitis, radiation proctitis, Crohn’s disease, colorectal cancer, autism spectrum disorder, sclerosis, Parkinson’s disease, asthma, diarrhea | [15-21] |
Bile acids | Cholate, hyocholate, deoxycholate, taurohyocholate, ursodeoxycholate, taurocholate, tauro- α-muricholate, glycocholate, hyodeoxycholate, tauro- β-muricholate, lithocholate, taurodeoxylcholate |
Directly act on FXR, VDR, PXR/SXR, constitutive androstane receptor (CAR), TGR5, sphingosine 1-phosphate receptor 2 (S1PR2), formyl-peptide receptor (FPR), muscarinic acetylcholine receptor (mAChR) | Facilitate lipid and vitamin absorption; regulation of gut microbiota composition, gut hormones, intestinal immunity, intestinal electrolyte and fluid balance, gut motility, lipid homeostasis, glucose homeostasis, amino acid homeostasis, circadian clocks; influence neurotransmission and physiology | Primary biliary cholangitis, primary sclerosing cholangitis, obesity, nonalcoholic fatty liver disease, non-alcoholic steatohepatitis, atherosclerosis, ulcerative colitis, cancer, hepatic encephalopathy, multiple sclerosis, Alzheimer's disease, Parkinson's disease, traumatic brain injury, stroke and amyotrophic lateral sclerosis | [8,22-25] |
Gases | H2S, H2, CO2, CH4, NO | NO targets soluble guanylate cyclase, H2S cause conformational changes of target proteins by sulfhydration | CH4 slows gut motility; H2S regulates gut inflammation, motility, epithelial secretion and susceptibility to infections; NO mediates gastric mucosal protection and regulate mucosal blood flow | Parkinson’s disease, colitis, ulcer | [26-31] |
Tryptophan and indole derivatives | Indole-3-lactic acid, indole acetic acid, indole-3-acetamide, indole pyruvic acid, indoxyl sulfuric acid, indole, serotonin | Directly targeting on AhR and PXR | Influence the gut microbial spore formation, drug resistance, biofilm formation, and virulence; regulate intestinal barrier functions, gut hormone secretion, gut motility, systemic immune response | Ulcerative colitis, Crohn’s disease, obesity, stroke, mucosal candidiasis, autism spectrum disorder, Alzheimer’s disease, Parkinson's disease, migraine, schizophrenia, irritable bowel syndrome | [32-36] |
Choline metabolites | TMA, methylamine, dimethylglycine, dimethylamine, | Direct target unknown, but can activate NF-кB, protein kinase C (PKC), NLRP3 inflammasome | Inhibits bile acid synthesis; promote inflammation, thrombosis; affects myocardial hypertrophy and fibrosis; exacerbates mitochondrial dysfunction | Nonalcoholic fatty liver disease, obesity, atherosclerosis, diabetes, heart failure, hypertension | [37-39] |
Vitamins | Vitamin B2, Vitamin B3, Vitamin B5, Vitamin B6, Vitamin B9, Vitamin B12, vitamin K | Vitamin receptors | Involved in cellular metabolism; modulate immune function and cell proliferation; supply vitamins for hosts | Vitamin associated diseases such as schizophrenia, autism, and dementia | [40,41] |
Neurotransmitters | Dopamine, catecholamines, 5-HT, and GABA | Adrenergic receptors, 5-HT receptors, GABA receptors | Regulate gut motility, memory and stress responses, immune function of nervous system | Parkinson's disease, autism | [27,42,43] |
Lipids | Conjugated fatty acids, cholesterol, phosphatidylcholines, triglycerides, LPS |
LPS targets directly on TLR4 | LPS triggers systemic inflammation; conjugated fatty acids regulate hyperinsulinemia, immune system, lipoprotein profiles; cholesterol acts as material bases for bile acid synthesis. | Diabetes, obesity, nonalcoholic fatty liver disease, hyperinsulinemia, hypercholesterolemia, chronic hepatitis C. | [7,44,45] |
Others | Ethanol; triphosadenine; lantibiotic such as ruminococcin A and cytolysin; microcin such as microcin B17; organic acids such as benzoate and hippurate; polyamines such as cadaverine, and spermidine | Triphosadenine activate P2X and P2Y receptors | Enhance or damage gut barrier; regulate intestinal or systemic immune response; act as antibiotics to modulate gut microbiota composition; supply the nutrients; be toxic to host cells | Fatty liver disease, C. difficile and H. pylori infections, irritable bowel syndrome, ulcerative colitis | [7,46-48] |